Call us: 1.877.283.7882 | Monday–Friday: 8:00 AM–4:30 PM ET
Category: DNA, Paternity and Genetic testing
According to The New York Times, two separate studies recently published in the New England Journal of Medicine revealed that a mutation in a certain gene known as TREM2 may hinder the immune system's ability to protect the brain from Alzheimer's disease.
The news source reported that when the gene is not mutated, white blood cells in the brain are able to clean up the plaque known as beta amyloid that builds up and causes Alzheimer's. With the mutation, patients are at an increased risk of developing the disease.
One of the study authors, John Hardy, Ph.D., of the University College London referred to the gene's normal state as a "safety net," as quoted by the news source, and with the mutation, people "are living without a safety net."
This research has implications for a new Alzheimer's treatment, and Alison Goate, a researcher at Washington University in St. Louis, Missouri who was involved with one of the studies, reported that this would give the healthcare industry a new approach to combating the disease.
Details of the studies
In order to find the gene, researchers in one of the studies, led by Kari Stefansson, M.D., of deCODE Genetics in Iceland, analyzed the genomes of 2,261 patients and found TREM2. The investigators discovered that those with Alzheimer's were more likely to have the mutation in TREM2 than those who did not.
In the second study, Hardy, along with Rita Guerreiro, Ph.D., of the University College London and Andrew Singleton Ph.D., of the National Institute on Aging, were investigating patients who suffered from a rare disease in which they experienced symptoms of dementia and crumbling bones. The researchers came across the TREM2 mutation, and upon further investigation, they found that those who had the mutation were more likely to have Alzheimer's.
Alzheimer's statistics and diagnosis
According to the Alzheimer's Association, 5.4 million Americans are living with the disease and it has the sixth highest fatality rate in the U.S.
In order to be diagnosed with the condition, the National Institutes of Health (NIH), reports that a physician will give a complete physical exam, question the patient about medical history and provide a mental status test. The NIH also notes that many times, doctors will do a lab test to rule out other causes, such as chronic infection, vitamin deficiency or intoxication from medication.
Related Articles from Private MD:
News Categories:Advanced Lipid Treatment I Allergy Testing Anemia and RBC disorders Autoimmune Diseases Bariatric Lab Testing Blood and Blood Diseases Breast Cancer Detection and Tumor Markers Celiac Disease Testing Chlamydia Coagulation and blood clotting disorders Colon Diabetes DNA, Paternity and Genetic testing Drug Screening Environmental Toxin Testing Female Specific Tests Gastrointestinal Diseases General Health General Wellness Heart Health and Cholesterol Herpes HIV HIV monitoring/Treatment/Testing/Post Diagnos Hormones and Metabolism Infectious Diseases Infertility Testing-Male Infertitlity Hormone Testing Kidney Diseases Leukemia and WBC disorders Liver Liver Diseases Lyme Disease Male Specific Tests Menopause/Peri-Menopausal Diagnosis Musculoskeletal Diseases Organ Specific Testing Ovarian Prostate Sexually Transmitted Diseases Thyroid Diseases Transgender Hormone Testing-female to male Transgender Hormone Testing-Male to Female Vitamin D Deficiency-Diagnosis and Treatment
Visit the Health News Archive: Click Here
Questions about online blood testing or how to order a lab test? Click here to get started or call us toll-free at 1.877.283.7882. Our professionals are ready to assist you.Back to top